XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity and Stock-Based Compensation
 9 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Stockholders' Equity and Stock-Based Compensation

Note 5 – Stockholders' Equity and Stock-Based Compensation 

 

A summary of our unvested Restricted Shares and Restricted Stock Units ("RSUs") activity for the nine months ended March 31, 2020 is presented in the table below:

 

   Restricted
Shares		   Restricted
Stock Units		   Total   Weighted Average Grant Date Fair Value 
Nonvested at July 1, 2019   215,063    -    215,063   $11.99 
Granted   -    359,554    359,554    7.64 
Vested   (86,654)   (10,223)   (96,877)   11.40 
Forfeited   (52,755)   (24,210)   (76,965)   10.04 
Nonvested at March 31, 2020   75,654    325,121    400,775   $8.61 

 

For the three and nine months ended March 31, 2020, stock-based compensation expense related to the ratable amortization of the unvested Restricted Shares and RSUs was $0.3 million and $0.8 million, respectively, and $3.1 million of total unrecognized costs related to Restricted Shares and RSUs will be ratably recognized over an estimated weighted average remaining vesting period of 3.2 years.

 

Warrants 

 

A summary of the status of outstanding warrants to purchase common stock at March 31, 2020 and the changes during the nine months then ended, is presented in the following table:

 

   Shares
Issuable
upon
Exercise of
Warrants		   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Life
(in years)		 
Outstanding at July 1, 2019   6,183,115   $11.50    3.72 
Issued   -    -    - 
Exercised   (369,311)   11.50    - 
Expired/cancelled   -    -    - 
Outstanding at March 31, 2020   5,813,804   $11.50    2.89 

 

There was no aggregate intrinsic value for the warrants outstanding as of March 31, 2020.